פאנדי 50 יח'מל ( פקטור 8 )

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

FACTOR VIII (HUMAN)

MAH:

MEDICI MEDICAL LTD, ISRAEL

ATC_code:

B02BD02

pharmaceutical_form:

אבקה להכנת תמיסה לזריקה

composition:

FACTOR VIII (HUMAN) 500 IU

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA

therapeutic_group:

COAGULATION FACTOR VIII

therapeutic_area:

COAGULATION FACTOR VIII

therapeutic_indication:

Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.

authorization_date:

2020-12-31